Johanna Lahdenranta

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Diffusion Weighted

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Rigby, Gavin Bennett, Liuhong Chen, Gemma E Mudd, Helen Harrison, Paul J Beswick, Katerine van Rietschoten, Sophie M Watcham, Heather S Scott, Amy N Brown, Peter U Park, Carly Campbell, Eric Haines, Johanna Lahdenranta, Michael J Skynner, Phil Jeffrey, Nicholas Keen, Kevin Lee
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Molecular cancer therapeutics 21 (12) (2022)
Yifei Wang, Xiangjun Tian, Wendong Zhang, Zhongting Zhang, Rossana Lazcano, Pooja Hingorani, Michael E Roth, Jonathan D Gill, Douglas J Harrison, Zhaohui Xu, Sylvester Jusu, Sankaranarayanan Kannan, Jing Wang, Alexander J F Lazar, Eric Jay Earley, Stephen W Erickson, Tara Gelb, Philip Huxley, Johanna Lahdenranta, Gemma E Mudd, Raushan T Kurmasheva, Peter J Houghton, Malcolm A Smith, Edward Anders Kolb, Richard G Gorlick
Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma. Molecular cancer therapeutics 21 (6) (2022)
Gavin Bennett, Amy N Brown, Gemma E Mudd, Philip Huxley, Katerine Van Rietschoten, Silvia Pavan, Liuhong Chen, Sophie Watcham, Johanna Lahdenranta, Nicholas Keen
MMAE Delivery Using the Bicycle Toxin Conjugate BT5528. Molecular cancer therapeutics 19 (7) (2020)